

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.19565446 |
| 2 | cellular ketone body metabolic process (GO:0046950) | 4.86890042 |
| 3 | inositol phosphate catabolic process (GO:0071545) | 4.80830468 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.76800800 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.76800800 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.76800800 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.76800800 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.76800800 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.76800800 |
| 10 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.65450306 |
| 11 | inositol phosphate dephosphorylation (GO:0046855) | 4.65450306 |
| 12 | ketone body metabolic process (GO:1902224) | 4.38183532 |
| 13 | regulation of glucokinase activity (GO:0033131) | 4.26042349 |
| 14 | regulation of hexokinase activity (GO:1903299) | 4.26042349 |
| 15 | endocrine pancreas development (GO:0031018) | 4.17556296 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.08839197 |
| 17 | microglial cell activation (GO:0001774) | 4.03906791 |
| 18 | polyol catabolic process (GO:0046174) | 4.02338432 |
| 19 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.01898459 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 3.97646777 |
| 21 | insulin secretion (GO:0030073) | 3.96253169 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.93902867 |
| 23 | positive regulation of glycolytic process (GO:0045821) | 3.86381487 |
| 24 | apoptotic cell clearance (GO:0043277) | 3.84679440 |
| 25 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.81191190 |
| 26 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.76794391 |
| 27 | peptide hormone processing (GO:0016486) | 3.69807533 |
| 28 | auditory receptor cell differentiation (GO:0042491) | 3.55807612 |
| 29 | epithelial cell fate commitment (GO:0072148) | 3.55535664 |
| 30 | respiratory chain complex IV assembly (GO:0008535) | 3.55477671 |
| 31 | positive regulation of insulin secretion (GO:0032024) | 3.53583325 |
| 32 | positive regulation of interferon-alpha production (GO:0032727) | 3.51774348 |
| 33 | lactate metabolic process (GO:0006089) | 3.47155976 |
| 34 | positive regulation of protein autophosphorylation (GO:0031954) | 3.45467547 |
| 35 | glycerophospholipid catabolic process (GO:0046475) | 3.43726500 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.43207344 |
| 37 | response to host immune response (GO:0052572) | 3.43207344 |
| 38 | cytochrome complex assembly (GO:0017004) | 3.36522709 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.32097761 |
| 40 | detection of calcium ion (GO:0005513) | 3.31275087 |
| 41 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.30258535 |
| 42 | regulation of interferon-alpha production (GO:0032647) | 3.30157260 |
| 43 | signal peptide processing (GO:0006465) | 3.28427394 |
| 44 | cell adhesion mediated by integrin (GO:0033627) | 3.26871998 |
| 45 | positive regulation of peptide hormone secretion (GO:0090277) | 3.23938187 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.22169599 |
| 47 | response to host (GO:0075136) | 3.22169599 |
| 48 | response to host defenses (GO:0052200) | 3.22169599 |
| 49 | nitric oxide mediated signal transduction (GO:0007263) | 3.21521064 |
| 50 | cellular response to interferon-alpha (GO:0035457) | 3.18004970 |
| 51 | keratinocyte development (GO:0003334) | 3.14272407 |
| 52 | prostate gland growth (GO:0060736) | 3.12353180 |
| 53 | positive regulation of peptide secretion (GO:0002793) | 3.10391461 |
| 54 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.09619300 |
| 55 | macrophage activation (GO:0042116) | 3.07867992 |
| 56 | neutrophil activation involved in immune response (GO:0002283) | 3.05235231 |
| 57 | positive regulation of calcium ion import (GO:0090280) | 3.03139182 |
| 58 | positive regulation of macrophage cytokine production (GO:0060907) | 3.01210104 |
| 59 | positive regulation of actin filament depolymerization (GO:0030836) | 2.99879949 |
| 60 | regulation of cholesterol storage (GO:0010885) | 2.97761510 |
| 61 | kidney morphogenesis (GO:0060993) | 2.97175281 |
| 62 | detection of molecule of bacterial origin (GO:0032490) | 2.96987744 |
| 63 | nitric oxide biosynthetic process (GO:0006809) | 2.96902753 |
| 64 | positive regulation of gluconeogenesis (GO:0045722) | 2.95987262 |
| 65 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.91828406 |
| 66 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.88454726 |
| 67 | magnesium ion transport (GO:0015693) | 2.88343895 |
| 68 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.85628107 |
| 69 | platelet dense granule organization (GO:0060155) | 2.84618115 |
| 70 | negative regulation of protein oligomerization (GO:0032460) | 2.83857445 |
| 71 | negative regulation of neurological system process (GO:0031645) | 2.83455125 |
| 72 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.83402443 |
| 73 | positive regulation of p38MAPK cascade (GO:1900745) | 2.82546791 |
| 74 | I-kappaB phosphorylation (GO:0007252) | 2.81003340 |
| 75 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.79793191 |
| 76 | protein localization to cilium (GO:0061512) | 2.78059468 |
| 77 | parental behavior (GO:0060746) | 2.77488850 |
| 78 | regulation of B cell apoptotic process (GO:0002902) | 2.75760074 |
| 79 | regulation of mononuclear cell migration (GO:0071675) | 2.72701592 |
| 80 | negative regulation of complement activation (GO:0045916) | 2.72646659 |
| 81 | glomerular visceral epithelial cell development (GO:0072015) | 2.70262674 |
| 82 | peptide hormone secretion (GO:0030072) | 2.70067711 |
| 83 | response to peptidoglycan (GO:0032494) | 2.69681184 |
| 84 | wound healing, spreading of epidermal cells (GO:0035313) | 2.69381580 |
| 85 | glandular epithelial cell differentiation (GO:0002067) | 2.68958315 |
| 86 | keratan sulfate catabolic process (GO:0042340) | 2.68554198 |
| 87 | positive regulation of macroautophagy (GO:0016239) | 2.68478335 |
| 88 | adhesion of symbiont to host cell (GO:0044650) | 2.68164987 |
| 89 | virion attachment to host cell (GO:0019062) | 2.68164987 |
| 90 | regulation of energy homeostasis (GO:2000505) | 2.67169752 |
| 91 | peptide secretion (GO:0002790) | 2.66979036 |
| 92 | retinol metabolic process (GO:0042572) | 2.66652067 |
| 93 | inositol phosphate-mediated signaling (GO:0048016) | 2.66615680 |
| 94 | regulation of macrophage cytokine production (GO:0010935) | 2.66029487 |
| 95 | response to pheromone (GO:0019236) | 2.65653486 |
| 96 | surfactant homeostasis (GO:0043129) | 2.64313461 |
| 97 | regulation of insulin secretion (GO:0050796) | 2.63998867 |
| 98 | negative regulation of gluconeogenesis (GO:0045721) | 2.63463871 |
| 99 | negative regulation of lipid storage (GO:0010888) | 2.61866971 |
| 100 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.60808746 |
| 101 | protein prenylation (GO:0018342) | 2.60589339 |
| 102 | prenylation (GO:0097354) | 2.60589339 |
| 103 | dentate gyrus development (GO:0021542) | 2.60075853 |
| 104 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.59431140 |
| 105 | response to interferon-alpha (GO:0035455) | 2.59041672 |
| 106 | hemidesmosome assembly (GO:0031581) | 2.58074257 |
| 107 | Golgi to endosome transport (GO:0006895) | 2.57475510 |
| 108 | alanine transport (GO:0032328) | 2.57333132 |
| 109 | brain morphogenesis (GO:0048854) | 2.56363743 |
| 110 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.56081754 |
| 111 | regulation of macrophage chemotaxis (GO:0010758) | 2.55643193 |
| 112 | zinc ion transport (GO:0006829) | 2.55481626 |
| 113 | response to laminar fluid shear stress (GO:0034616) | 2.55352861 |
| 114 | glucosamine-containing compound catabolic process (GO:1901072) | 2.54900961 |
| 115 | negative regulation of acute inflammatory response (GO:0002674) | 2.54304160 |
| 116 | growth hormone receptor signaling pathway (GO:0060396) | 2.53799913 |
| 117 | adhesion of symbiont to host (GO:0044406) | 2.53226718 |
| 118 | regulation of execution phase of apoptosis (GO:1900117) | 2.52039872 |
| 119 | regulation of Rac protein signal transduction (GO:0035020) | 2.50790721 |
| 120 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.50783016 |
| 121 | positive regulation of hormone secretion (GO:0046887) | 2.50579830 |
| 122 | low-density lipoprotein particle clearance (GO:0034383) | 2.50321929 |
| 123 | sphingomyelin metabolic process (GO:0006684) | 2.50173114 |
| 124 | positive regulation of response to nutrient levels (GO:0032109) | 2.49620579 |
| 125 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.49620579 |
| 126 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.49206932 |
| 127 | negative regulation of hormone metabolic process (GO:0032351) | 2.49077754 |
| 128 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.49066723 |
| 129 | type B pancreatic cell development (GO:0003323) | 2.48886146 |
| 130 | proline transport (GO:0015824) | 2.48837500 |
| 131 | immunoglobulin mediated immune response (GO:0016064) | 2.48460265 |
| 132 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.47825046 |
| 133 | regulation of protein glycosylation (GO:0060049) | 2.47567321 |
| 134 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.47401411 |
| 135 | L-phenylalanine catabolic process (GO:0006559) | 2.47291310 |
| 136 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.47291310 |
| 137 | protein complex biogenesis (GO:0070271) | 2.45883428 |
| 138 | glomerular epithelial cell development (GO:0072310) | 2.45794317 |
| 139 | phagocytosis, engulfment (GO:0006911) | 2.45126766 |
| 140 | macroautophagy (GO:0016236) | 2.44142460 |
| 141 | negative regulation of granulocyte differentiation (GO:0030853) | 2.44135405 |
| 142 | xenobiotic catabolic process (GO:0042178) | 2.42941836 |
| 143 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.42928871 |
| 144 | L-phenylalanine metabolic process (GO:0006558) | 2.42928871 |
| 145 | regulation of peptide hormone secretion (GO:0090276) | 2.42820200 |
| 146 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.40922068 |
| 147 | axoneme assembly (GO:0035082) | 2.40475959 |
| 148 | positive regulation of cholesterol efflux (GO:0010875) | 2.39313986 |
| 149 | regulation of protein autophosphorylation (GO:0031952) | 2.38869423 |
| 150 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.38625715 |
| 151 | peptide transport (GO:0015833) | 2.38567722 |
| 152 | eosinophil chemotaxis (GO:0048245) | 2.38112671 |
| 153 | endodermal cell differentiation (GO:0035987) | 2.37959124 |
| 154 | nodal signaling pathway (GO:0038092) | 2.37908665 |
| 155 | regulation of autophagic vacuole assembly (GO:2000785) | 2.37798719 |
| 156 | positive regulation of antigen processing and presentation (GO:0002579) | 2.37327952 |
| 157 | transcytosis (GO:0045056) | 2.36954359 |
| 158 | regulation of peptide secretion (GO:0002791) | 2.36559611 |
| 159 | thyroid hormone metabolic process (GO:0042403) | 2.36340862 |
| 160 | basement membrane organization (GO:0071711) | 2.35286961 |
| 161 | negative regulation of protein activation cascade (GO:2000258) | 2.34441488 |
| 162 | substrate-dependent cell migration (GO:0006929) | 2.34259321 |
| 163 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.33519718 |
| 164 | lymph vessel development (GO:0001945) | 2.31071011 |
| 165 | response to fluid shear stress (GO:0034405) | 2.30200529 |
| 166 | regulation of monocyte chemotaxis (GO:0090025) | 2.30174695 |
| 167 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.30124519 |
| 168 | positive regulation of interferon-beta production (GO:0032728) | 2.29068362 |
| 169 | positive regulation of chemokine production (GO:0032722) | 2.28419173 |
| 170 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.27151607 |
| 171 | positive regulation of chemokine secretion (GO:0090197) | 2.26919188 |
| 172 | myeloid cell activation involved in immune response (GO:0002275) | 2.25164796 |
| 173 | cellular extravasation (GO:0045123) | 2.24731960 |
| 174 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.23468972 |
| 175 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.23186233 |
| 176 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.22676680 |
| 177 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.22543729 |
| 178 | T-helper 1 type immune response (GO:0042088) | 2.21552070 |
| 179 | collagen metabolic process (GO:0032963) | 2.20771750 |
| 180 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.20134257 |
| 181 | protein localization to endosome (GO:0036010) | 2.19209085 |
| 182 | collagen catabolic process (GO:0030574) | 2.19198020 |
| 183 | axon extension involved in axon guidance (GO:0048846) | 2.18528287 |
| 184 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.18528287 |
| 185 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.18120330 |
| 186 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.18061640 |
| 187 | response to muramyl dipeptide (GO:0032495) | 2.15922938 |
| 188 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.15653124 |
| 189 | granulocyte activation (GO:0036230) | 2.15421646 |
| 190 | protein heterotrimerization (GO:0070208) | 2.14864647 |
| 191 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.14823074 |
| 192 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.13676538 |
| 193 | cellular response to growth hormone stimulus (GO:0071378) | 2.13180157 |
| 194 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.13042250 |
| 195 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.12922532 |
| 196 | positive regulation of osteoblast proliferation (GO:0033690) | 2.12214033 |
| 197 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.11387481 |
| 198 | lung lobe morphogenesis (GO:0060463) | 2.11325597 |
| 199 | phagocytosis, recognition (GO:0006910) | 2.11308444 |
| 200 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.11167334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.48508304 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.40632700 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.45259934 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.04204404 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.02873485 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.98452136 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.70335513 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.65261451 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64182789 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.52342399 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.47376623 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.44108153 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43960226 |
| 14 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.43191077 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.42286427 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34064398 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.18920340 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.13174126 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11804305 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.03740020 |
| 21 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.98699834 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97877223 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.97775986 |
| 24 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.91456052 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.90117278 |
| 26 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.85403519 |
| 27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.84217858 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.83093580 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82124714 |
| 30 | CJUN_26792858_Chip-Seq_BT549_Human | 1.81896650 |
| 31 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.81838077 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.81781824 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.81685046 |
| 34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.78629392 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77418705 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.77416098 |
| 37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.75293184 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69835715 |
| 39 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.67820439 |
| 40 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67556990 |
| 41 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.62928519 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.62790553 |
| 43 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.60875505 |
| 44 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.58536710 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.58531596 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57827493 |
| 47 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57251741 |
| 48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.55075979 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.54136688 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53792651 |
| 51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53792651 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.51828544 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.51826296 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.51279082 |
| 55 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.50755954 |
| 56 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.50401915 |
| 57 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49158426 |
| 58 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.48738893 |
| 59 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47854160 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47228652 |
| 61 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47024646 |
| 62 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.46270932 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45603094 |
| 64 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.41672271 |
| 65 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41643625 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41169129 |
| 67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.39880635 |
| 68 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.39826544 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39565092 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.38366106 |
| 71 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38221435 |
| 72 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37981351 |
| 73 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.37708065 |
| 74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37584648 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37536347 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37335535 |
| 77 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.36947653 |
| 78 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.36651304 |
| 79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35771457 |
| 80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35737593 |
| 81 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.35442280 |
| 82 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.35434430 |
| 83 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34437739 |
| 84 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32182432 |
| 85 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31521051 |
| 86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29894441 |
| 87 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29867842 |
| 88 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.29183606 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28858766 |
| 90 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.28187695 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27563650 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26551138 |
| 93 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.25887217 |
| 94 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.25887217 |
| 95 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.24616577 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.24507839 |
| 97 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.23462866 |
| 98 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.23462866 |
| 99 | TCF4_23295773_ChIP-Seq_U87_Human | 1.23335451 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23068465 |
| 101 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22908173 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21914689 |
| 103 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21722827 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21589435 |
| 105 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.20578444 |
| 106 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.20033191 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19701291 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18938886 |
| 109 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.18924023 |
| 110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18745037 |
| 111 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18073536 |
| 112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17379086 |
| 113 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.16144186 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16023033 |
| 115 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.15639846 |
| 116 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15459301 |
| 117 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14941440 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14758959 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14758959 |
| 120 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.14491549 |
| 121 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.14491549 |
| 122 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.14469966 |
| 123 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14467704 |
| 124 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13180975 |
| 125 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12907770 |
| 126 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12805376 |
| 127 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11810624 |
| 128 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.11582855 |
| 129 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.11462303 |
| 130 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11439555 |
| 131 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10948641 |
| 132 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.10603150 |
| 133 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09828288 |
| 134 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08256744 |
| 135 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08163760 |
| 136 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.08135786 |
| 137 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08074127 |
| 138 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07042594 |
| 139 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06777338 |
| 140 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.06746179 |
| 141 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05164032 |
| 142 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04744017 |
| 143 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03503871 |
| 144 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03458422 |
| 145 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03180855 |
| 146 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02408252 |
| 147 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.02372781 |
| 148 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01879334 |
| 149 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.00971721 |
| 150 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.00666984 |
| 151 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00665012 |
| 152 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00060871 |
| 153 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99254174 |
| 154 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.99151804 |
| 155 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.98917957 |
| 156 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.98196232 |
| 157 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97850578 |
| 158 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97265236 |
| 159 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97029151 |
| 160 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96831037 |
| 161 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95911572 |
| 162 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94907184 |
| 163 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94636969 |
| 164 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94415625 |
| 165 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.94277267 |
| 166 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93844166 |
| 167 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93788447 |
| 168 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93788447 |
| 169 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91323680 |
| 170 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90958287 |
| 171 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90615673 |
| 172 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89326061 |
| 173 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88722921 |
| 174 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88372008 |
| 175 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87303975 |
| 176 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.87118268 |
| 177 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86603593 |
| 178 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86207493 |
| 179 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.84677242 |
| 180 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84600419 |
| 181 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.84047082 |
| 182 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.83608435 |
| 183 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82115439 |
| 184 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80736527 |
| 185 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.80133596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.80499701 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 4.27900359 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 4.16393823 |
| 4 | MP0005379_endocrine/exocrine_gland_phen | 3.78169814 |
| 5 | MP0003195_calcinosis | 3.71252078 |
| 6 | MP0002163_abnormal_gland_morphology | 3.06857760 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.03507881 |
| 8 | MP0005275_abnormal_skin_tensile | 2.94644254 |
| 9 | MP0002909_abnormal_adrenal_gland | 2.90907556 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.86096597 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.79532734 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.76726472 |
| 13 | MP0003787_abnormal_imprinting | 2.74556386 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.62579412 |
| 15 | MP0002254_reproductive_system_inflammat | 2.57394402 |
| 16 | MP0001944_abnormal_pancreas_morphology | 2.56672872 |
| 17 | MP0002693_abnormal_pancreas_physiology | 2.40210102 |
| 18 | MP0002876_abnormal_thyroid_physiology | 2.37858043 |
| 19 | MP0001958_emphysema | 2.37494449 |
| 20 | MP0003724_increased_susceptibility_to | 2.36124414 |
| 21 | MP0006082_CNS_inflammation | 2.30360985 |
| 22 | MP0003279_aneurysm | 2.26625610 |
| 23 | MP0003283_abnormal_digestive_organ | 2.07757269 |
| 24 | MP0006072_abnormal_retinal_apoptosis | 2.04783463 |
| 25 | MP0003436_decreased_susceptibility_to | 2.02992177 |
| 26 | MP0010386_abnormal_urinary_bladder | 2.01575053 |
| 27 | MP0004272_abnormal_basement_membrane | 2.00399249 |
| 28 | MP0005646_abnormal_pituitary_gland | 2.00313153 |
| 29 | MP0003303_peritoneal_inflammation | 1.99458168 |
| 30 | MP0008877_abnormal_DNA_methylation | 1.98968774 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.97361156 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.91313768 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.91130426 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.89161063 |
| 35 | MP0005503_abnormal_tendon_morphology | 1.85648409 |
| 36 | MP0000343_altered_response_to | 1.84121510 |
| 37 | MP0001756_abnormal_urination | 1.82253449 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.82231033 |
| 39 | MP0002419_abnormal_innate_immunity | 1.81939730 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.81102227 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.78761278 |
| 42 | MP0005220_abnormal_exocrine_pancreas | 1.71069212 |
| 43 | MP0003075_altered_response_to | 1.70996245 |
| 44 | MP0001879_abnormal_lymphatic_vessel | 1.66521336 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.64771122 |
| 46 | MP0009384_cardiac_valve_regurgitation | 1.64483803 |
| 47 | MP0003828_pulmonary_edema | 1.64446637 |
| 48 | MP0003690_abnormal_glial_cell | 1.63640731 |
| 49 | MP0003122_maternal_imprinting | 1.63397207 |
| 50 | MP0000767_abnormal_smooth_muscle | 1.63287349 |
| 51 | MP0009046_muscle_twitch | 1.62238606 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.55618905 |
| 53 | MP0001984_abnormal_olfaction | 1.55582038 |
| 54 | MP0004019_abnormal_vitamin_homeostasis | 1.53656441 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.53506921 |
| 56 | MP0003045_fibrosis | 1.50270934 |
| 57 | MP0005023_abnormal_wound_healing | 1.48250020 |
| 58 | MP0009785_altered_susceptibility_to | 1.48051926 |
| 59 | MP0005164_abnormal_response_to | 1.46416734 |
| 60 | MP0010329_abnormal_lipoprotein_level | 1.44631153 |
| 61 | MP0005332_abnormal_amino_acid | 1.44548266 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.43628308 |
| 63 | MP0000427_abnormal_hair_cycle | 1.43319338 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 1.43061883 |
| 65 | MP0009840_abnormal_foam_cell | 1.42731812 |
| 66 | MP0004510_myositis | 1.42088715 |
| 67 | MP0003448_altered_tumor_morphology | 1.40198447 |
| 68 | MP0002060_abnormal_skin_morphology | 1.38143999 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 1.38078900 |
| 70 | MP0002928_abnormal_bile_duct | 1.35773964 |
| 71 | MP0004043_abnormal_pH_regulation | 1.34512997 |
| 72 | MP0009278_abnormal_bone_marrow | 1.34377672 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 1.33002215 |
| 74 | MP0005365_abnormal_bile_salt | 1.32717053 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 1.32264574 |
| 76 | MP0003091_abnormal_cell_migration | 1.31659814 |
| 77 | MP0005390_skeleton_phenotype | 1.31200695 |
| 78 | MP0005174_abnormal_tail_pigmentation | 1.30014371 |
| 79 | MP0002295_abnormal_pulmonary_circulatio | 1.29029724 |
| 80 | MP0005257_abnormal_intraocular_pressure | 1.28842274 |
| 81 | MP0005253_abnormal_eye_physiology | 1.28157534 |
| 82 | MP0005000_abnormal_immune_tolerance | 1.28014033 |
| 83 | MP0004947_skin_inflammation | 1.26874693 |
| 84 | MP0000538_abnormal_urinary_bladder | 1.26642770 |
| 85 | MP0005084_abnormal_gallbladder_morpholo | 1.26485657 |
| 86 | MP0006054_spinal_hemorrhage | 1.25815935 |
| 87 | MP0005025_abnormal_response_to | 1.25173289 |
| 88 | MP0005166_decreased_susceptibility_to | 1.24688992 |
| 89 | MP0005387_immune_system_phenotype | 1.23320373 |
| 90 | MP0001790_abnormal_immune_system | 1.23320373 |
| 91 | MP0009764_decreased_sensitivity_to | 1.23267255 |
| 92 | MP0001501_abnormal_sleep_pattern | 1.22785960 |
| 93 | MP0000569_abnormal_digit_pigmentation | 1.20216932 |
| 94 | MP0001851_eye_inflammation | 1.20111441 |
| 95 | MP0000003_abnormal_adipose_tissue | 1.19395090 |
| 96 | MP0000372_irregular_coat_pigmentation | 1.19266967 |
| 97 | MP0004270_analgesia | 1.18599611 |
| 98 | MP0002638_abnormal_pupillary_reflex | 1.17770656 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 1.15802921 |
| 100 | MP0001661_extended_life_span | 1.14999313 |
| 101 | MP0002452_abnormal_antigen_presenting | 1.12968163 |
| 102 | MP0002090_abnormal_vision | 1.12511861 |
| 103 | MP0005464_abnormal_platelet_physiology | 1.11993931 |
| 104 | MP0004883_abnormal_blood_vessel | 1.11913964 |
| 105 | MP0002166_altered_tumor_susceptibility | 1.11371504 |
| 106 | MP0002282_abnormal_trachea_morphology | 1.11307742 |
| 107 | MP0001986_abnormal_taste_sensitivity | 1.09587760 |
| 108 | MP0008004_abnormal_stomach_pH | 1.07743090 |
| 109 | MP0005636_abnormal_mineral_homeostasis | 1.06380646 |
| 110 | MP0001765_abnormal_ion_homeostasis | 1.06056298 |
| 111 | MP0003633_abnormal_nervous_system | 1.05627622 |
| 112 | MP0004885_abnormal_endolymph | 1.04208527 |
| 113 | MP0005623_abnormal_meninges_morphology | 1.03445403 |
| 114 | MP0000685_abnormal_immune_system | 1.00982519 |
| 115 | MP0009745_abnormal_behavioral_response | 1.00899755 |
| 116 | MP0005508_abnormal_skeleton_morphology | 1.00698182 |
| 117 | MP0000249_abnormal_blood_vessel | 1.00236338 |
| 118 | MP0002933_joint_inflammation | 0.99898017 |
| 119 | MP0003953_abnormal_hormone_level | 0.99743584 |
| 120 | MP0002006_tumorigenesis | 0.99628821 |
| 121 | MP0010678_abnormal_skin_adnexa | 0.99395759 |
| 122 | MP0005448_abnormal_energy_balance | 0.99208621 |
| 123 | MP0002796_impaired_skin_barrier | 0.98264800 |
| 124 | MP0001542_abnormal_bone_strength | 0.98141745 |
| 125 | MP0004215_abnormal_myocardial_fiber | 0.98061101 |
| 126 | MP0000516_abnormal_urinary_system | 0.97508517 |
| 127 | MP0005367_renal/urinary_system_phenotyp | 0.97508517 |
| 128 | MP0000639_abnormal_adrenal_gland | 0.96212131 |
| 129 | MP0002938_white_spotting | 0.95269036 |
| 130 | MP0005535_abnormal_body_temperature | 0.93668393 |
| 131 | MP0001764_abnormal_homeostasis | 0.93622642 |
| 132 | MP0001881_abnormal_mammary_gland | 0.93527798 |
| 133 | MP0002896_abnormal_bone_mineralization | 0.93392411 |
| 134 | MP0005248_abnormal_Harderian_gland | 0.92441917 |
| 135 | MP0005076_abnormal_cell_differentiation | 0.91866210 |
| 136 | MP0002133_abnormal_respiratory_system | 0.91533387 |
| 137 | MP0005388_respiratory_system_phenotype | 0.91533387 |
| 138 | MP0001845_abnormal_inflammatory_respons | 0.91426022 |
| 139 | MP0003121_genomic_imprinting | 0.91239753 |
| 140 | MP0000733_abnormal_muscle_development | 0.91072034 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.90800314 |
| 142 | MP0008469_abnormal_protein_level | 0.90714143 |
| 143 | MP0000604_amyloidosis | 0.90674653 |
| 144 | MP0002168_other_aberrant_phenotype | 0.89136424 |
| 145 | MP0002118_abnormal_lipid_homeostasis | 0.88175644 |
| 146 | MP0005165_increased_susceptibility_to | 0.87904484 |
| 147 | MP0003941_abnormal_skin_development | 0.87438985 |
| 148 | MP0000015_abnormal_ear_pigmentation | 0.87320069 |
| 149 | MP0003123_paternal_imprinting | 0.87196322 |
| 150 | MP0003795_abnormal_bone_structure | 0.87025506 |
| 151 | MP0002102_abnormal_ear_morphology | 0.86879513 |
| 152 | MP0005670_abnormal_white_adipose | 0.86623918 |
| 153 | MP0010155_abnormal_intestine_physiology | 0.85270816 |
| 154 | MP0002723_abnormal_immune_serum | 0.84744596 |
| 155 | MP0001853_heart_inflammation | 0.84730376 |
| 156 | MP0005075_abnormal_melanosome_morpholog | 0.84076418 |
| 157 | MP0002405_respiratory_system_inflammati | 0.84051219 |
| 158 | MP0004133_heterotaxia | 0.83955623 |
| 159 | MP0000383_abnormal_hair_follicle | 0.83600998 |
| 160 | MP0004130_abnormal_muscle_cell | 0.82051788 |
| 161 | MP0001905_abnormal_dopamine_level | 0.81833421 |
| 162 | MP0010352_gastrointestinal_tract_polyps | 0.81593171 |
| 163 | MP0005197_abnormal_uvea_morphology | 0.81258782 |
| 164 | MP0009643_abnormal_urine_homeostasis | 0.81040391 |
| 165 | MP0005171_absent_coat_pigmentation | 0.80827304 |
| 166 | MP0001216_abnormal_epidermal_layer | 0.80698661 |
| 167 | MP0000631_abnormal_neuroendocrine_gland | 0.79333027 |
| 168 | MP0008872_abnormal_physiological_respon | 0.79108079 |
| 169 | MP0002064_seizures | 0.77250602 |
| 170 | MP0000230_abnormal_systemic_arterial | 0.77214681 |
| 171 | MP0003252_abnormal_bile_duct | 0.77175631 |
| 172 | MP0004484_altered_response_of | 0.73579439 |
| 173 | MP0005647_abnormal_sex_gland | 0.73509656 |
| 174 | MP0002277_abnormal_respiratory_mucosa | 0.73407350 |
| 175 | MP0003011_delayed_dark_adaptation | 0.73174975 |
| 176 | MP0005389_reproductive_system_phenotype | 0.72663503 |
| 177 | MP0006036_abnormal_mitochondrial_physio | 0.71746831 |
| 178 | MP0001970_abnormal_pain_threshold | 0.70982193 |
| 179 | MP0002557_abnormal_social/conspecific_i | 0.69325951 |
| 180 | MP0008875_abnormal_xenobiotic_pharmacok | 0.68237011 |
| 181 | MP0002229_neurodegeneration | 0.67797041 |
| 182 | MP0000613_abnormal_salivary_gland | 0.67282435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.42464638 |
| 2 | Hypothermia (HP:0002045) | 4.48296979 |
| 3 | Glomerulonephritis (HP:0000099) | 4.27757399 |
| 4 | Hyperglycemia (HP:0003074) | 4.21646610 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.15560890 |
| 6 | Ketoacidosis (HP:0001993) | 4.13623534 |
| 7 | Hypoglycemic coma (HP:0001325) | 3.84767653 |
| 8 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.81424934 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.73067561 |
| 10 | Hematochezia (HP:0002573) | 3.72894778 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.72364376 |
| 12 | Hypoglycemic seizures (HP:0002173) | 3.70068688 |
| 13 | Hemiparesis (HP:0001269) | 3.61156948 |
| 14 | Cerebral aneurysm (HP:0004944) | 3.59123891 |
| 15 | Hamartoma of the eye (HP:0010568) | 3.54118583 |
| 16 | Nephritis (HP:0000123) | 3.52049250 |
| 17 | Enlarged penis (HP:0000040) | 3.47913173 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.44707189 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.43628247 |
| 20 | Axonal loss (HP:0003447) | 3.43384905 |
| 21 | Arterial tortuosity (HP:0005116) | 3.41783778 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.38209719 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.37154757 |
| 24 | Conjunctival hamartoma (HP:0100780) | 3.37050405 |
| 25 | Increased CSF protein (HP:0002922) | 3.33462407 |
| 26 | Aortic aneurysm (HP:0004942) | 3.33036126 |
| 27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.23414032 |
| 28 | Osteolytic defects of the hand bones (HP:0009699) | 3.23414032 |
| 29 | Vascular tortuosity (HP:0004948) | 3.20938347 |
| 30 | Abnormality of vitamin B metabolism (HP:0004340) | 3.19218606 |
| 31 | Neoplasm of the adrenal cortex (HP:0100641) | 3.17024695 |
| 32 | Aortic dissection (HP:0002647) | 3.16864183 |
| 33 | Premature rupture of membranes (HP:0001788) | 3.16258390 |
| 34 | Tongue fasciculations (HP:0001308) | 3.15785300 |
| 35 | Large for gestational age (HP:0001520) | 3.14826251 |
| 36 | Cervical subluxation (HP:0003308) | 3.13481592 |
| 37 | Complement deficiency (HP:0004431) | 3.13421675 |
| 38 | Progressive macrocephaly (HP:0004481) | 3.04597651 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.99873701 |
| 40 | Thick nail (HP:0001805) | 2.99757086 |
| 41 | Atrophic scars (HP:0001075) | 2.98704643 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.96586744 |
| 43 | Protrusio acetabuli (HP:0003179) | 2.87599921 |
| 44 | Metaphyseal dysplasia (HP:0100255) | 2.87522723 |
| 45 | Congenital sensorineural hearing impairment (HP:0008527) | 2.85337940 |
| 46 | Ketosis (HP:0001946) | 2.83990534 |
| 47 | Myocardial infarction (HP:0001658) | 2.81834880 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.80612904 |
| 49 | Mucopolysacchariduria (HP:0008155) | 2.80612904 |
| 50 | Congenital malformation of the right heart (HP:0011723) | 2.76891621 |
| 51 | Double outlet right ventricle (HP:0001719) | 2.76891621 |
| 52 | Hypoalbuminemia (HP:0003073) | 2.76301018 |
| 53 | Abnormal albumin level (HP:0012116) | 2.76301018 |
| 54 | Follicular hyperkeratosis (HP:0007502) | 2.75472404 |
| 55 | Methylmalonic acidemia (HP:0002912) | 2.68239262 |
| 56 | Muscle fibrillation (HP:0010546) | 2.65998692 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.65039687 |
| 58 | Abnormality of complement system (HP:0005339) | 2.64738208 |
| 59 | Shallow orbits (HP:0000586) | 2.63766286 |
| 60 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.63669837 |
| 61 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.63669837 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.62972576 |
| 63 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.56620932 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.55520677 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.55520677 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.55520677 |
| 67 | Abnormality of vitamin metabolism (HP:0100508) | 2.54809160 |
| 68 | Disinhibition (HP:0000734) | 2.54745603 |
| 69 | Symptomatic seizures (HP:0011145) | 2.54061491 |
| 70 | Intestinal atresia (HP:0011100) | 2.52767866 |
| 71 | Hyperthyroidism (HP:0000836) | 2.49666132 |
| 72 | Abnormality of glycolipid metabolism (HP:0010969) | 2.49239112 |
| 73 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.49239112 |
| 74 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.49239112 |
| 75 | Broad metatarsal (HP:0001783) | 2.48165468 |
| 76 | Abnormality of the renal cortex (HP:0011035) | 2.44972211 |
| 77 | Pancreatic fibrosis (HP:0100732) | 2.44971255 |
| 78 | Nephronophthisis (HP:0000090) | 2.44389899 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.42694428 |
| 80 | Furrowed tongue (HP:0000221) | 2.42451039 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.42149524 |
| 82 | Late onset (HP:0003584) | 2.41131842 |
| 83 | Vascular calcification (HP:0004934) | 2.41002049 |
| 84 | Spondylolisthesis (HP:0003302) | 2.40220591 |
| 85 | Testicular neoplasm (HP:0010788) | 2.38250966 |
| 86 | Hypomagnesemia (HP:0002917) | 2.34907755 |
| 87 | Agitation (HP:0000713) | 2.32551099 |
| 88 | Polydipsia (HP:0001959) | 2.32451842 |
| 89 | Abnormal drinking behavior (HP:0030082) | 2.32451842 |
| 90 | Thyroiditis (HP:0100646) | 2.31981771 |
| 91 | Ankle contracture (HP:0006466) | 2.31706727 |
| 92 | Right ventricular cardiomyopathy (HP:0011663) | 2.31608353 |
| 93 | Cutaneous melanoma (HP:0012056) | 2.25901245 |
| 94 | Mitral valve prolapse (HP:0001634) | 2.24929988 |
| 95 | Abnormality of urine glucose concentration (HP:0011016) | 2.24501840 |
| 96 | Glycosuria (HP:0003076) | 2.24501840 |
| 97 | Vertebral compression fractures (HP:0002953) | 2.24154756 |
| 98 | Gaze-evoked nystagmus (HP:0000640) | 2.23926565 |
| 99 | Pancreatic cysts (HP:0001737) | 2.22888752 |
| 100 | Postural tremor (HP:0002174) | 2.22340566 |
| 101 | Peritonitis (HP:0002586) | 2.21334533 |
| 102 | Aqueductal stenosis (HP:0002410) | 2.21286835 |
| 103 | Gingivitis (HP:0000230) | 2.20396773 |
| 104 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.17645982 |
| 105 | Medial flaring of the eyebrow (HP:0010747) | 2.17554758 |
| 106 | Tubular atrophy (HP:0000092) | 2.17253890 |
| 107 | Acute necrotizing encephalopathy (HP:0006965) | 2.16737544 |
| 108 | Neoplasm of the adrenal gland (HP:0100631) | 2.16539787 |
| 109 | Hypoplasia of the fovea (HP:0007750) | 2.15521526 |
| 110 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.15521526 |
| 111 | Congenital stationary night blindness (HP:0007642) | 2.13673630 |
| 112 | Cardiovascular calcification (HP:0011915) | 2.12436329 |
| 113 | Renal cortical cysts (HP:0000803) | 2.10932874 |
| 114 | Albinism (HP:0001022) | 2.09751201 |
| 115 | Abnormality of the lumbar spine (HP:0100712) | 2.09572330 |
| 116 | Disproportionate short-trunk short stature (HP:0003521) | 2.07906643 |
| 117 | Methylmalonic aciduria (HP:0012120) | 2.07545712 |
| 118 | Soft skin (HP:0000977) | 2.07236653 |
| 119 | Periodontitis (HP:0000704) | 2.04818646 |
| 120 | Esophageal varix (HP:0002040) | 2.03330559 |
| 121 | Disproportionate tall stature (HP:0001519) | 2.02950439 |
| 122 | Prostate neoplasm (HP:0100787) | 2.01807399 |
| 123 | EEG with generalized epileptiform discharges (HP:0011198) | 2.01409625 |
| 124 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.00598194 |
| 125 | Pulmonary artery stenosis (HP:0004415) | 2.00437315 |
| 126 | Abnormality of the renal medulla (HP:0100957) | 2.00268177 |
| 127 | Molar tooth sign on MRI (HP:0002419) | 1.99896010 |
| 128 | Abnormality of midbrain morphology (HP:0002418) | 1.99896010 |
| 129 | Dilatation of the ascending aorta (HP:0005111) | 1.99604011 |
| 130 | Milia (HP:0001056) | 1.98555721 |
| 131 | Abnormal pancreas size (HP:0012094) | 1.97667597 |
| 132 | Pustule (HP:0200039) | 1.97422346 |
| 133 | Hypoplasia of the iris (HP:0007676) | 1.96498815 |
| 134 | Hepatic necrosis (HP:0002605) | 1.96460541 |
| 135 | True hermaphroditism (HP:0010459) | 1.96296382 |
| 136 | Epileptiform EEG discharges (HP:0011182) | 1.94518230 |
| 137 | Attenuation of retinal blood vessels (HP:0007843) | 1.94478496 |
| 138 | Blue sclerae (HP:0000592) | 1.93341362 |
| 139 | Abnormality of proline metabolism (HP:0010907) | 1.92414429 |
| 140 | Hydroxyprolinuria (HP:0003080) | 1.92414429 |
| 141 | Delayed gross motor development (HP:0002194) | 1.92364444 |
| 142 | Tetraparesis (HP:0002273) | 1.90111445 |
| 143 | Fragile skin (HP:0001030) | 1.89550202 |
| 144 | Aneurysm (HP:0002617) | 1.88078861 |
| 145 | Progressive neurologic deterioration (HP:0002344) | 1.87159376 |
| 146 | Mitochondrial inheritance (HP:0001427) | 1.86878115 |
| 147 | Hypokinesia (HP:0002375) | 1.85536974 |
| 148 | 3-Methylglutaconic aciduria (HP:0003535) | 1.84997267 |
| 149 | Hypsarrhythmia (HP:0002521) | 1.84955188 |
| 150 | Stridor (HP:0010307) | 1.84919818 |
| 151 | Macroorchidism (HP:0000053) | 1.84853388 |
| 152 | Bone pain (HP:0002653) | 1.83044788 |
| 153 | Epiphyseal dysplasia (HP:0002656) | 1.82653619 |
| 154 | Absent frontal sinuses (HP:0002688) | 1.82104674 |
| 155 | Episodic fever (HP:0001954) | 1.82022086 |
| 156 | Muscular hypotonia of the trunk (HP:0008936) | 1.81972801 |
| 157 | Camptodactyly of toe (HP:0001836) | 1.80391051 |
| 158 | Orchitis (HP:0100796) | 1.79694548 |
| 159 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.79293152 |
| 160 | Bone cyst (HP:0012062) | 1.79073371 |
| 161 | Mediastinal lymphadenopathy (HP:0100721) | 1.78491010 |
| 162 | Increased CSF lactate (HP:0002490) | 1.77462452 |
| 163 | Focal segmental glomerulosclerosis (HP:0000097) | 1.75992135 |
| 164 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.74762265 |
| 165 | Alopecia of scalp (HP:0002293) | 1.74677134 |
| 166 | Severe muscular hypotonia (HP:0006829) | 1.74523480 |
| 167 | Persistence of primary teeth (HP:0006335) | 1.71517884 |
| 168 | Neonatal short-limb short stature (HP:0008921) | 1.70923980 |
| 169 | Recurrent skin infections (HP:0001581) | 1.69946675 |
| 170 | Premature loss of primary teeth (HP:0006323) | 1.68793518 |
| 171 | Myositis (HP:0100614) | 1.68444813 |
| 172 | Onycholysis (HP:0001806) | 1.68325110 |
| 173 | Hepatosplenomegaly (HP:0001433) | 1.67636382 |
| 174 | Pathologic fracture (HP:0002756) | 1.67262670 |
| 175 | Ovoid vertebral bodies (HP:0003300) | 1.66706770 |
| 176 | Progressive visual loss (HP:0000529) | 1.66567712 |
| 177 | Plantar hyperkeratosis (HP:0007556) | 1.66392918 |
| 178 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.66379331 |
| 179 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.66270558 |
| 180 | Wormian bones (HP:0002645) | 1.65524985 |
| 181 | Striae distensae (HP:0001065) | 1.63462564 |
| 182 | Peripheral demyelination (HP:0011096) | 1.62638528 |
| 183 | Mutism (HP:0002300) | 1.62136786 |
| 184 | Basal ganglia calcification (HP:0002135) | 1.59230589 |
| 185 | Mesangial abnormality (HP:0001966) | 1.58901767 |
| 186 | Spinal rigidity (HP:0003306) | 1.58534944 |
| 187 | Amyloidosis (HP:0011034) | 1.55953410 |
| 188 | Femoral bowing (HP:0002980) | 1.55059002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.59761379 |
| 2 | MAP4K2 | 3.21062300 |
| 3 | CAMK1D | 2.51565257 |
| 4 | RIPK1 | 2.39000710 |
| 5 | GRK1 | 2.37192945 |
| 6 | TYK2 | 2.37161726 |
| 7 | EPHB1 | 2.33439382 |
| 8 | PHKG1 | 2.26915546 |
| 9 | PHKG2 | 2.26915546 |
| 10 | MAP3K14 | 2.18367954 |
| 11 | ERN1 | 2.16391741 |
| 12 | WNK3 | 2.01563066 |
| 13 | ADRBK2 | 1.97529734 |
| 14 | TBK1 | 1.97218002 |
| 15 | EPHA3 | 1.92040614 |
| 16 | DDR2 | 1.89924462 |
| 17 | CAMK1G | 1.89316074 |
| 18 | MST1R | 1.79572123 |
| 19 | JAK1 | 1.75558072 |
| 20 | TRIB3 | 1.74961831 |
| 21 | PAK3 | 1.67138263 |
| 22 | TTN | 1.67070464 |
| 23 | SIK1 | 1.66159045 |
| 24 | BLK | 1.65398628 |
| 25 | TRPM7 | 1.64279056 |
| 26 | GRK7 | 1.64004796 |
| 27 | DAPK2 | 1.61597408 |
| 28 | EPHB2 | 1.59187046 |
| 29 | PDGFRA | 1.58620332 |
| 30 | RIPK4 | 1.57396882 |
| 31 | PTK6 | 1.57023181 |
| 32 | ACVR1B | 1.54125988 |
| 33 | NLK | 1.52488044 |
| 34 | TIE1 | 1.50190391 |
| 35 | NTRK3 | 1.50030933 |
| 36 | MAPK15 | 1.47755508 |
| 37 | FER | 1.47243697 |
| 38 | CSK | 1.36084970 |
| 39 | INSRR | 1.31483450 |
| 40 | TNIK | 1.29246172 |
| 41 | IRAK4 | 1.28554308 |
| 42 | PRKCE | 1.26516739 |
| 43 | IRAK3 | 1.25626120 |
| 44 | FGFR3 | 1.25483992 |
| 45 | PINK1 | 1.21943759 |
| 46 | IKBKE | 1.21721253 |
| 47 | NEK9 | 1.21502856 |
| 48 | MET | 1.20964735 |
| 49 | PLK2 | 1.20412947 |
| 50 | PAK4 | 1.19076669 |
| 51 | CASK | 1.18981118 |
| 52 | STK10 | 1.18651015 |
| 53 | BMX | 1.18220396 |
| 54 | FGFR4 | 1.18049725 |
| 55 | CSF1R | 1.15833983 |
| 56 | KIT | 1.14036965 |
| 57 | PDGFRB | 1.13450236 |
| 58 | MAP3K12 | 1.11846447 |
| 59 | MAP3K3 | 1.11694158 |
| 60 | LATS1 | 1.11192606 |
| 61 | TRIM28 | 1.10521738 |
| 62 | FGR | 1.10208031 |
| 63 | DMPK | 1.09657764 |
| 64 | CSNK1G1 | 1.09067536 |
| 65 | BMPR2 | 1.08596493 |
| 66 | STK38L | 1.08105937 |
| 67 | IKBKB | 1.07233943 |
| 68 | MAP3K4 | 1.06935993 |
| 69 | MATK | 1.05225380 |
| 70 | OXSR1 | 1.05008797 |
| 71 | FRK | 1.04663042 |
| 72 | EIF2AK3 | 1.02373802 |
| 73 | MAP2K6 | 0.99089632 |
| 74 | LRRK2 | 0.98709815 |
| 75 | TAOK1 | 0.98314328 |
| 76 | LIMK1 | 0.98254089 |
| 77 | PRKD3 | 0.97256302 |
| 78 | PKN2 | 0.96464716 |
| 79 | STK3 | 0.96214648 |
| 80 | PBK | 0.94573945 |
| 81 | MKNK2 | 0.93493676 |
| 82 | JAK3 | 0.93450158 |
| 83 | MAP3K13 | 0.87531512 |
| 84 | CAMK2D | 0.86692705 |
| 85 | MST4 | 0.86691727 |
| 86 | JAK2 | 0.85865965 |
| 87 | HCK | 0.85765121 |
| 88 | PTK2 | 0.85053650 |
| 89 | ERBB3 | 0.84418743 |
| 90 | PDK2 | 0.83780418 |
| 91 | MAP3K2 | 0.83697333 |
| 92 | HIPK2 | 0.82890587 |
| 93 | CSNK1G2 | 0.82019218 |
| 94 | CHUK | 0.81877028 |
| 95 | NUAK1 | 0.80967979 |
| 96 | PIK3CA | 0.80776953 |
| 97 | GSK3A | 0.77572758 |
| 98 | EIF2AK1 | 0.76910744 |
| 99 | EPHA2 | 0.76256519 |
| 100 | CSNK1G3 | 0.75423964 |
| 101 | CDK6 | 0.74980772 |
| 102 | PTK2B | 0.73039518 |
| 103 | TGFBR1 | 0.71753812 |
| 104 | MOS | 0.71197840 |
| 105 | MARK3 | 0.69148917 |
| 106 | STK39 | 0.69041215 |
| 107 | WNK4 | 0.68119453 |
| 108 | STK11 | 0.67621133 |
| 109 | TNK2 | 0.66922439 |
| 110 | PRKCG | 0.65425833 |
| 111 | EGFR | 0.62727486 |
| 112 | PRKAA2 | 0.62004030 |
| 113 | MUSK | 0.61526514 |
| 114 | PRKD1 | 0.60614948 |
| 115 | IGF1R | 0.59992435 |
| 116 | PIM2 | 0.57073245 |
| 117 | PRKG2 | 0.56565215 |
| 118 | ABL1 | 0.56556302 |
| 119 | ADRBK1 | 0.56444958 |
| 120 | STK4 | 0.56267403 |
| 121 | PAK2 | 0.55830064 |
| 122 | PIK3CG | 0.55450280 |
| 123 | YES1 | 0.54617933 |
| 124 | PLK3 | 0.53838824 |
| 125 | INSR | 0.52224814 |
| 126 | PRKAA1 | 0.51994473 |
| 127 | CAMKK2 | 0.50368575 |
| 128 | PRKCI | 0.50260174 |
| 129 | LMTK2 | 0.49008992 |
| 130 | ZAP70 | 0.48449712 |
| 131 | RPS6KA4 | 0.48397003 |
| 132 | MAPKAPK2 | 0.46547485 |
| 133 | FGFR2 | 0.46259755 |
| 134 | SRC | 0.45169394 |
| 135 | MAPK13 | 0.44872917 |
| 136 | IRAK1 | 0.44186290 |
| 137 | MYLK | 0.43541564 |
| 138 | RET | 0.43217949 |
| 139 | MAPK12 | 0.42825976 |
| 140 | BMPR1B | 0.40618934 |
| 141 | PDPK1 | 0.40450740 |
| 142 | TAF1 | 0.40408842 |
| 143 | MAP2K7 | 0.40323745 |
| 144 | PRKCH | 0.40114744 |
| 145 | STK24 | 0.39175927 |
| 146 | MAP2K2 | 0.38871661 |
| 147 | AKT3 | 0.38857936 |
| 148 | CAMK2A | 0.38404224 |
| 149 | MAPK7 | 0.37858757 |
| 150 | LYN | 0.37618873 |
| 151 | PRKD2 | 0.37565251 |
| 152 | LCK | 0.37197389 |
| 153 | PRKG1 | 0.37049318 |
| 154 | ROCK1 | 0.36826284 |
| 155 | CSNK1A1L | 0.36002609 |
| 156 | MAPKAPK3 | 0.34085320 |
| 157 | CSNK1A1 | 0.31102051 |
| 158 | ZAK | 0.29956883 |
| 159 | PRKACA | 0.29081208 |
| 160 | CDC42BPA | 0.29061405 |
| 161 | STK16 | 0.26927649 |
| 162 | PASK | 0.24701793 |
| 163 | PRKCA | 0.24469808 |
| 164 | PRKCZ | 0.21484877 |
| 165 | OBSCN | 0.19962078 |
| 166 | PRKCQ | 0.19957062 |
| 167 | ROCK2 | 0.19890229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.17989998 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.43376254 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.09382400 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.03316626 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.72646903 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.71905323 |
| 7 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.55300141 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.51768233 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.43777693 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.21583475 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.20475644 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 2.19285931 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.18800436 |
| 14 | Malaria_Homo sapiens_hsa05144 | 2.15817000 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04069681 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.99622895 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.96898806 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.95045473 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93138742 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.92226020 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.79514172 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73047345 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69728779 |
| 24 | Amoebiasis_Homo sapiens_hsa05146 | 1.63116016 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.62835938 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.59712173 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.56936160 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53212250 |
| 29 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.53160389 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.52187365 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.48491916 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.47970114 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45741742 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43935963 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43536376 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.42874762 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40359000 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.39337095 |
| 39 | Adherens junction_Homo sapiens_hsa04520 | 1.37323423 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.37058451 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.35304207 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.32969443 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32898576 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.31763287 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.31368238 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30803342 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30686316 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.30135931 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.27191571 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25332687 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.22993874 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.20368489 |
| 53 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.15571198 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13901142 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12231466 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 1.11723575 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10428901 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07480328 |
| 59 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06669655 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05489130 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04419898 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03462568 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 1.03072783 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.03031064 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01392638 |
| 66 | Measles_Homo sapiens_hsa05162 | 1.01334954 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99934470 |
| 68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.98999145 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.97902753 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96548979 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.95105519 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94838929 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94050501 |
| 74 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.93815505 |
| 75 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.91704071 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.91140649 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90797013 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89430626 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87635591 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.87081845 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86476264 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86121936 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85014685 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.83955936 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.83047591 |
| 86 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82996606 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.81351939 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80169003 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79950012 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79928463 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79910815 |
| 92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.79727317 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79149256 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.78858941 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78403325 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.77934949 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77427445 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.77189148 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76847849 |
| 100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.74736210 |
| 101 | Hepatitis B_Homo sapiens_hsa05161 | 0.74476981 |
| 102 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73834953 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73805249 |
| 104 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73669335 |
| 105 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73560805 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72670873 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.71431826 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70658507 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69964373 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69527001 |
| 111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69379274 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69268530 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68999229 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66672241 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66473319 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.65397520 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65345831 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65259623 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65083794 |
| 120 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64587851 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64488668 |
| 122 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64121869 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63977421 |
| 124 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62631073 |
| 125 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62005712 |
| 126 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61914503 |
| 127 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61603964 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60832210 |
| 129 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60381528 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60083344 |
| 131 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59475370 |
| 132 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.59050779 |
| 133 | Salivary secretion_Homo sapiens_hsa04970 | 0.58881605 |
| 134 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58306494 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58091420 |
| 136 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.57564378 |
| 137 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57235511 |
| 138 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56642007 |
| 139 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54952580 |
| 140 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53361547 |
| 141 | Pathways in cancer_Homo sapiens_hsa05200 | 0.52831602 |
| 142 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52131708 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52035226 |
| 144 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51831191 |
| 145 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51688726 |
| 146 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51619357 |
| 147 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51477140 |
| 148 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51429994 |
| 149 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50786079 |
| 150 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50401231 |
| 151 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50149480 |
| 152 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50030732 |
| 153 | Melanoma_Homo sapiens_hsa05218 | 0.49239667 |
| 154 | Prostate cancer_Homo sapiens_hsa05215 | 0.49077297 |
| 155 | Allograft rejection_Homo sapiens_hsa05330 | 0.49046970 |
| 156 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48756660 |
| 157 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48659663 |
| 158 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48202666 |
| 159 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47140522 |
| 160 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46568825 |
| 161 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45419902 |
| 162 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45382404 |
| 163 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45244691 |
| 164 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44399499 |
| 165 | Asthma_Homo sapiens_hsa05310 | 0.43819354 |
| 166 | Bladder cancer_Homo sapiens_hsa05219 | 0.43307628 |
| 167 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41430613 |
| 168 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40786921 |
| 169 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40026207 |
| 170 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39937827 |
| 171 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35725261 |
| 172 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34200281 |
| 173 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34103204 |
| 174 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33814958 |
| 175 | Morphine addiction_Homo sapiens_hsa05032 | 0.33039701 |
| 176 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32940782 |
| 177 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.31394102 |
| 178 | Basal transcription factors_Homo sapiens_hsa03022 | 0.30728712 |
| 179 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30690022 |
| 180 | Taste transduction_Homo sapiens_hsa04742 | 0.28415631 |

